Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Financial Flexibility Index
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Financial Flexibility Index of 0.28x as of September 2025. Free cash flow of CN¥70.03 Million (operating CF CN¥58.18 Million minus capex CN¥11.85 Million) represents 0% of total liabilities (CN¥247.20 Million). Check 002365 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Qianjiang Yongan Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see how efficiently does Qianjiang Yongan Pharmaceutical Co Ltd generate cash.
Annual Financial Flexibility Index for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Qianjiang Yongan Pharmaceutical Co Ltd. Explore 002365 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.84x | CN¥223.76 Million | CN¥105.71 Million | CN¥266.55 Million | ▼ -31.3% |
| 2023 | 1.22x | CN¥365.00 Million | CN¥244.26 Million | CN¥298.85 Million | ▼ -26.9% |
| 2022 | 1.67x | CN¥536.35 Million | CN¥387.28 Million | CN¥321.17 Million | ▲ +233.2% |
| 2021 | 0.50x | CN¥164.86 Million | CN¥101.81 Million | CN¥328.95 Million | ▼ -43.6% |
| 2020 | 0.89x | CN¥311.07 Million | CN¥206.66 Million | CN¥349.92 Million | ▼ -40.3% |
| 2019 | 1.49x | CN¥373.94 Million | CN¥239.55 Million | CN¥251.14 Million | ▼ -17.5% |
| 2018 | 1.81x | CN¥583.52 Million | CN¥314.02 Million | CN¥323.11 Million | ▼ -12.7% |
| 2017 | 2.07x | CN¥486.79 Million | CN¥197.32 Million | CN¥235.23 Million | ▲ +59.7% |
| 2016 | 1.30x | CN¥124.66 Million | CN¥84.53 Million | CN¥96.22 Million | ▲ +3.3% |
| 2015 | 1.25x | CN¥104.73 Million | CN¥70.61 Million | CN¥83.50 Million | ▲ +41.9% |
| 2014 | 0.88x | CN¥69.95 Million | CN¥19.26 Million | CN¥79.14 Million | ▼ -33.8% |
| 2013 | 1.34x | CN¥163.57 Million | CN¥63.65 Million | CN¥122.50 Million | ▼ -18.5% |
| 2012 | 1.64x | CN¥190.93 Million | CN¥70.75 Million | CN¥116.59 Million | ▼ -49.7% |
| 2011 | 3.26x | CN¥339.26 Million | CN¥91.23 Million | CN¥104.13 Million | ▲ +67.0% |
| 2010 | 1.95x | CN¥148.58 Million | CN¥44.06 Million | CN¥76.14 Million | ▲ +65.4% |
| 2009 | 1.18x | CN¥82.41 Million | CN¥36.43 Million | CN¥69.83 Million | ▼ -38.6% |
| 2008 | 1.92x | CN¥230.66 Million | CN¥158.47 Million | CN¥120.04 Million | ▼ -0.8% |
| 2007 | 1.94x | CN¥121.85 Million | CN¥61.08 Million | CN¥62.89 Million | ▲ +83.6% |
| 2006 | 1.06x | CN¥48.79 Million | CN¥31.11 Million | CN¥46.24 Million | — |